Skip to content

TimeWarp LabsTimeWarp Labs

Cart

Your cart is empty

Signup for our newsletter

Describe what your customers will receive when subscribing to your newsletter.
01Capsule 01
02Capsule 02
03Capsule 03
04Capsule 04

Cellular evolution for the next decade of you.

Protocol 01 · Founder's Edition · Summer 2026
Request Access
250 units reserved. Admission by application.
A Protocol. Not a Supplement.A Protocol. Not a Supplement.A Protocol. Not a Supplement.A Protocol. Not a Supplement.A Protocol. Not a Supplement.A Protocol. Not a Supplement.A Protocol. Not a Supplement.A Protocol. Not a Supplement.

A system, not a stack.

Aging is not a single failure. It is a network of interacting pathways that decline together. TimeWarp Protocol 01 is a serialized daily system designed for that reality: a coordinated set of compounds, dosed and sequenced to act across the full biology of aging. Six capsules a day. One monthly cleanse. No stack to assemble.

240
Longevity compounds screened
40,000+
Biological interactions evaluated
2,600
Evidence dossiers compiled
37,000+
Literature searches executed
TimeWarp Research Framework · 2024 to 2026

Four capsules. One system.

01
Core
Cellular infrastructure. Daily
02
Energize
Mitochondrial output. Daily
03
Protect
Oxidative defense. Daily
04
Cleanse
Senolytic clearance. Monthly
Full ingredient specifications disclosed on delivery.

Built against the Hallmarks of Aging.

Every compound in Protocol 01 is mapped to a specific cluster of aging biology, scored against evidence, and selected for how it interacts with the rest of the system. Each capsule targets a defined domain. Together, they cover the full matrix.

Read the framework

Advisory disclosed in sequence.

Protocol 01 was built in dialogue with scientists working at the edge of aging biology, epigenetic research, and systems-level longevity. Their names will be released ahead of public launch.

The Founder's Edition.

The first 250 units of Protocol 01 are reserved for the Founder's Edition. Admission is by application. Founder's Edition members receive:

  • First access at public launch
  • Advisory briefs ahead of public release
  • Direct line to the formulation team
  • Priority allocation on Protocol 02
Apply for Founder's Edition
Specifications
Release
Protocol 01
Format
6 capsules daily + 2 capsules monthly
Capsule
#00, vegan
Category
Daily longevity system
First shipment
Summer 2026
Manufacturing
FDA-registered facility, United States
Allocation
250 Founder's Edition units
Application
Open. Rolling review.

Admission closes at 250.

Review is rolling. Late applications are held for Protocol 02.

Request Access

Apply for the Founder's Edition.

Review is rolling. Response within five business days.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.